Key Takeaways
- • McDermott Will & Emery represented Public Pension Capital in a private equity investment in Life Science Outsourcing, Inc., completed January 25, 2021, positioning the firm as a leading advisor in healthcare PE transactions.
- • Life Science Outsourcing, a Brea, California-based medical device contract manufacturer, provides critical outsourced services including package testing, validation, sterilization, and distribution to over 850 medical device companies.
- • Public Pension Capital, a New York-based PE fund founded by former senior KKR partners, targets select industries including Business and Financial Services, Industrial Services, and Healthcare Services, leveraging deep operational expertise in value-creation strategies.
- • McDermott assembled a 16-person legal team led by Kristian Werling to execute the transaction, demonstrating the firm's substantial healthcare PE capabilities and ranked status as the top healthcare private equity advisor by deal volume according to Pitchbook.
Summary
McDermott Will & Emery served as legal counsel to Public Pension Capital in its acquisition of Life Science Outsourcing, Inc., a transaction completed on January 25, 2021. The deal represents a significant engagement for the international law firm in the healthcare private equity sector, where it maintains leadership positioning by deal volume.
Life Science Outsourcing operates as a specialized medical device contract manufacturer headquartered in Brea, California. The company provides essential outsourced services encompassing package testing, validation, sterilization, and distribution capabilities to medical device manufacturers. The firm has established relationships with more than 850 medical device startups and established companies, positioning itself as a critical partner in accelerating product development cycles and enabling customers to bring increasingly complex and innovative commercial medical devices to market.
Public Pension Capital, the acquiring fund, is based in New York and was founded by former senior partners of Kohlberg Kravis Roberts & Co. The fund pursues a focused investment strategy across select industries, including Business and Financial Services, Industrial Services, and Healthcare Services. This investment in Life Science Outsourcing aligns with Public Pension Capital's healthcare services thesis and reflects confidence in the outsourced medical device manufacturing sector.
The McDermott legal team executing the transaction was led by partner Kristian Werling and included 15 additional attorneys: William Hadler, Elaine Kao, Dan Zucker, Vernessa Pollard, Anisa Mohanty, Ike Chidi, Daniel Doron, Sarah Schanz, Allison Wilkerson, Sarah Raaii, Jed Gordon, Warren Zeserman, David Neville, Kate Williams, and Mark Bilut. McDermott Will & Emery maintains over 100 private equity specialists and is ranked as the leading firm in healthcare private equity by deal volume, according to Pitchbook, underscoring the firm's substantial institutional capacity in this practice area.
Life Science Outsourcing operates as a specialized medical device contract manufacturer headquartered in Brea, California. The company provides essential outsourced services encompassing package testing, validation, sterilization, and distribution capabilities to medical device manufacturers. The firm has established relationships with more than 850 medical device startups and established companies, positioning itself as a critical partner in accelerating product development cycles and enabling customers to bring increasingly complex and innovative commercial medical devices to market.
Public Pension Capital, the acquiring fund, is based in New York and was founded by former senior partners of Kohlberg Kravis Roberts & Co. The fund pursues a focused investment strategy across select industries, including Business and Financial Services, Industrial Services, and Healthcare Services. This investment in Life Science Outsourcing aligns with Public Pension Capital's healthcare services thesis and reflects confidence in the outsourced medical device manufacturing sector.
The McDermott legal team executing the transaction was led by partner Kristian Werling and included 15 additional attorneys: William Hadler, Elaine Kao, Dan Zucker, Vernessa Pollard, Anisa Mohanty, Ike Chidi, Daniel Doron, Sarah Schanz, Allison Wilkerson, Sarah Raaii, Jed Gordon, Warren Zeserman, David Neville, Kate Williams, and Mark Bilut. McDermott Will & Emery maintains over 100 private equity specialists and is ranked as the leading firm in healthcare private equity by deal volume, according to Pitchbook, underscoring the firm's substantial institutional capacity in this practice area.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.